Sandoz and subsidiary Fougera Pharmaceuticals agreed to pay $265 million to direct pharmaceutical purchasers over generic drug price-fixing claims…. Read More
The post Sandoz to pay $265M in generic drug price-fixing settlement appeared first on Top Class Actions.